XML 36 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Balance Sheet Components
 3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Balance Sheet Components Balance Sheet Components
Inventories consist of the following as of the periods indicated:

(in thousands)March 31, 2024December 31, 2023
Raw materials$23,793 $24,406 
Finished goods71,928 66,915 
Total inventories $95,721 $91,321 

Accrued payroll-related expenses consist of the following as of the periods indicated:

(in thousands)March 31, 2024December 31, 2023
Accrued compensation and payroll taxes
$7,296 $10,458 
Accrued sales commissions5,572 7,565 
Accrued benefits2,588 4,005 
Total accrued payroll-related expenses$15,456 $22,028 
Other accrued expenses consist of the following as of the periods indicated:

(in thousands)March 31, 2024December 31, 2023
Sales and VAT tax payables$4,328 $4,971 
Accrued interest4,219 2,344 
Royalty liabilities3,783 3,914 
Other12,065 8,617 
Total other accrued expenses$24,395 $19,846 

As of March 31, 2024 and December 31, 2023, the Company has approximately $12 million and $15 million, respectively, of non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture or assemble final products for the Company, which is included in prepaid expenses and other current assets on the Consolidated Balance Sheets. The Company purchases components directly from suppliers and do not reflect the sale of these components to the manufacturing vendors in net sales.
As of March 31, 2024 and December 31, 2023, total warranty reserve was approximately $7 million and $6 million, respectively. As of March 31, 2024, approximately $5 million was included in other accrued expenses and approximately $2 million was included in other long-term liabilities on the Condensed Consolidated Balance Sheets. As of December 31, 2023, approximately $4 million was included in other accrued expenses and approximately $2 million was included in other long-term liabilities on the Consolidated Balance Sheets.
As of March 31, 2024, the Company has approximately $2 million in restricted cash held as collateral for the Company’s credit cards.